Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm Infants
Author:
Affiliation:
1. Evidera, Bethesda, MD, USA
2. Children’s Hospital Los Angeles, Los Angeles, CA, USA
3. University of Southern California, Los Angeles, CA, USA
4. Emory University School of Medicine, Atlanta, GA, USA
5. AstraZeneca, Gaithersburg, MD, USA
Funder
AstraZeneca
Publisher
SAGE Publications
Subject
Pediatrics, Perinatology and Child Health
Link
http://journals.sagepub.com/doi/pdf/10.1177/0009922819843639
Reference23 articles.
1. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
2. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
3. Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of Age
4. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants
5. Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of Child Respiratory Syncytial Virus-Confirmed Infections on Caregivers in Japan: A Web-Based Survey;Journal of Clinical Medicine;2024-09-10
2. Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain;BMC Infectious Diseases;2024-01-18
3. Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022;Vaccine;2023-11
4. The Estimate of Parental Quality of Life Loss Due to Respiratory Syncytial Virus (RSV) Hospitalization;Diseases;2023-09-24
5. Evaluation of Antibody-based Preventive Alternatives for Respiratory Syncytial Virus: A Novel Multi-Criteria Decision Analysis Framework and Assessment of Nirsevimab in Spain;2023-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3